crypto currency basics, Overview

Market News: Bain and GIC, the largest investment institution in Singapore, seek to sell shares of JUDO CAPITAL worth A $131 million.Hang Seng Index fell 0.2%, led by Meituan. The Hang Seng Index fell 0.2% to 20,278.66 in Hong Kong for two consecutive days. Meituan dragged down the index the most, falling by 1.7%. Chuangke Industrial Co., Ltd. suffered the biggest decline, falling by 4.1%. In midday trading, 33 of the 83 stocks fell and 46 rose; Three of the four stocks fell, led by industrial and commercial stocks.Hainan Free Trade Zone concept changed partially. Hainan Ruize and Hainan Development both had daily limit, Hainan Ruize and Hainan Development both had daily limit, and Lishang Guochao, Hainan Haiyao, Hainan Expressway and Huawen Group followed suit.

At midday, the main contract of alumina futures opened lower, and now it is down nearly 3% to 5101 yuan/ton. In the news, according to Shanghai Nonferrous Metals, on December 10th, 30,000 tons of alumina was sold overseas, with a transaction price of $680/mt FOB Western Australia, and the shipping date was in late January/early February.Burger King China: In November this year, the number of passengers turned positive year-on-year, and the sales in October increased by about 5% month-on-month. On December 11th, the relevant person in charge of Burger King China told reporters, "Since the government issued a package of incremental policies at the end of September, many chain catering enterprises including Burger King have felt the stabilization and recovery of the catering consumption market since October this year. Especially in the past November, Burger King has achieved a positive year-on-year passenger flow. " The aforementioned person in charge pointed out, "From the sales data, in the past six years, our sales in October were almost the same as that in September. However, in October this year, the sales of Burger King China rebounded from September, increasing by about 5%. " (The Paper)The global layout will further promote Sannuo Bio-CGM products to enter the European market. Recently, Sannuo Bio-CGM has reached a strategic cooperation with A.Menarini Diagnostics, a leading European medical diagnosis company, and signed an exclusive distribution agreement. The continuous glucose monitoring (CGM) products of Sannuo Bio will be launched in the European market in the form of joint brands of both parties. Sannuo Bio authorized A.Menarini Diagnostics to exclusively sell its CGM products in more than 20 countries and regions in Europe. In the future, the latter will vigorously promote the access, promotion and sales of Sannuo Bio CGM products in the European medical insurance market. Sannuo Bio has been actively deploying its internationalization strategy since its listing, and its iCan CGM is the first continuous glucose monitoring product certified by CE MDR in China. At present, Europe is the second largest market for CGM. In this cooperation, the two sides signed an exclusive distribution contract with considerable volume, which is expected to greatly accelerate the penetration and coverage of Sannuo Bio-CGM products in the European market.

A number of private placements are optimistic about the market at the end of the year, and the two major directions are favored. Recently, A-shares have fluctuated, and the latest strategies of a number of first-line private placements for investment at the end of the year and the beginning of the year have been released one after another. A number of private placements are optimistic about the market at the end of the year. Kou Zhiwei, a partner of chongyang investment, said that the "strengthening unconventional countercyclical adjustment" proposed by the policy at the end of the year inspired market confidence. At present, compared with the end of September, the market has a large increase, and the market has fully expected and priced the policy overweight. The further rise of the short-term market may need the support of strong economic recovery data. Lei, deputy general manager and chief strategic investment official of Xingshi Investment, said that the current positive factors in the stock market are still accumulating, and the fundamentals, policies and funds are all supported. Judging from the recent overall investment trends of private placement, the reporter found that maintaining medium and high positions and maintaining high flexibility of portfolios have become the strategic focus of current private placement institutions. Judging from the specific optimistic investment direction at the end of the year, according to the comprehensive interview with private equity, consumption and technology are relatively more popular at present. (CSI Taurus)An increase of 91.3%! In the first 11 months, there were more than 33.1 million people entering and leaving Shanghai port. Since last year, China has successively introduced or resumed various visa-free policies, and the level of entry and exit facilitation has been continuously improved. From January to November this year, Shanghai Border Inspection Station inspected 247,000 inbound and outbound means of transport at Shanghai Port, and inspected more than 33.1 million passengers, up 43.6% and 91.3% respectively over the same period last year. (CCTV News)Hanyu Pharmaceutical Co., Ltd. signed a strategic cooperation agreement with Longma Technology. Recently, Hanyu Biotechnology (Dali) Co., Ltd., a subsidiary of Hanyu Pharmaceutical Co., Ltd., signed a strategic cooperation agreement with Longma Technology Group. The two sides will cooperate in the medical application of industrial cannabis and drug research and development around drugs and cannabinoids.